erythromycin has been researched along with curcumin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| Cao, YH; Chang, HY; Huang, Y; Jiao, XY; Liu, JH; Ma, FC; Pan, KL; Zhu, HF | 1 |
| Gao, Y; Liu, W; Lu, Y; Pan, C; Yin, P; Yu, X; Zhou, Z | 1 |
| Li, W; Shang, K; Wang, X; Xiao, S; Zhang, L | 1 |
4 other study(ies) available for erythromycin and curcumin
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
[The study on reversing mechanism of multidrug resistance of K562/A02 cell line by curcumin and erythromycin].
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Proliferation; Cell Survival; Curcumin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Epirubicin; Erythromycin; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; K562 Cells; Leukemia, Erythroblastic, Acute; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2006 |
Combination of Erythromycin and Curcumin Alleviates
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Erythromycin; Interleukin-6; Male; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Tumor Necrosis Factor-alpha | 2017 |
A rapid anti-Helicobacter pylori biofilm drug screening biosensor based on AlpB outer membrane protein and colloidal gold/nanoporous gold framework.
Topics: Bacterial Outer Membrane Proteins; Biofilms; Biosensing Techniques; Curcumin; Drug Evaluation, Preclinical; Erythromycin; Gold Colloid; Helicobacter Infections; Helicobacter pylori; Humans; Membrane Proteins; Molecular Docking Simulation; Nanopores; Rifampin | 2022 |